Comparable Long-Term Outcomes Among DAS28-ESR-based Remission Criteria and ACR/EULAR Definitions in Patients with Established Rheumatoid Arthritis

被引:0
|
作者
Ramirez Garcia, Felipe Julio [1 ]
Inciarte-Mundo, Jose [2 ]
Cuervo, Andrea [3 ]
Celis, Raquel [3 ]
Ruiz-Esquide, Virginia [3 ]
Castellanos-Moreira, Raul [4 ]
Ponce, Andres [3 ]
Gomez-Puerta, Jose [2 ]
Sanmarti, Raimon [2 ]
Canete, Juan [1 ,5 ]
机构
[1] Hosp Clin Barcelona, Arthrit Unit, Dept Rheumatol, Barcelona, Spain
[2] Hosp Univ Clin Barcelona, Barcelona, Catalonia, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] IDIBAPS, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1756
引用
收藏
页数:3
相关论文
共 47 条
  • [21] Performance of Criteria for Remission in a Long-Term Observational Study of Patients with Early Rheumatoid Arthritis.
    Svensson, Bjorn
    Andersson, Maria L. E.
    Bala, Sidona-Valentina
    Forslind, Kristina
    Hafstrom, Ingiald
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S170 - S170
  • [22] DAS28 (ESR) Response at Week 12 is Predictive of Long-Term Disease Activity in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
    Schiff, Michael
    Keystone, Edward
    Kvien, Tore
    Curtis, Jeffrey
    Emery, Paul
    Luijtens, Kristel
    Choy, Ernest
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1332 - 1332
  • [23] The 2010 ACR/EULAR classification criteria for rheumatoid arthritis in the Heinola inception cohort-diagnoses confirmed by long-term follow-up
    Kaarela, Kalevi
    Kauppi, Jenni E.
    Kauppi, Markku J.
    CLINICAL RHEUMATOLOGY, 2012, 31 (03) : 547 - 551
  • [24] Successful Maintenance of Remission Defined by the New ACR/EULAR Criteria Leads to Better Functional Outcomes in Rheumatoid Arthritis in Daily Practice, Especially in Patients with Early RA, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort
    Shidara, Kumi
    Tanaka, Eiichi
    Inoue, Eisuke
    Seto, Yohei
    Nakajima, Ayako
    Momohara, Shigeki
    Taniguchi, Atsuo
    Yamanaka, Hisashi
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S124 - S124
  • [25] GOLIMUMAB ADMINISTERED SUBCUTANEOUSLY EVERY FOUR WEEKS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: LONG-TERM CLINICAL, RADIOGRAPHIC AND SAFETY RESULTS, INCLUDING EVALUATION OF REMISSION USING THE NEW ACR/EULAR CRITERIA
    Tanaka, Y.
    Harigai, M.
    Takeuchi, T.
    Yamanaka, H.
    Ishiguro, N.
    Yamamoto, K.
    Murakami, Y.
    Yoshinari, T.
    Baker, D.
    Miyasaka, N.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 442 - 442
  • [26] Lack Of Early Clinical Response To Treatment With Baricitinib Predicts Low Probability Of Achieving Long Term DAS28-ESR Low Disease Activity Or Remission In Patients With Rheumatoid Arthritis.
    Keystone, Edward
    Genovese, Mark C.
    Taylor, Peter
    Zhu, Baojin
    Beattie, Scott D.
    de Bono, Stephanie
    Rooney, Terence
    Schlichting, Douglas E.
    Macias, William
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S607 - S607
  • [27] INFLUENCE OF DOSE TITRATION OF CONCOMITANT STEROID AND METHOTREXATE DURING BIOLOGIC THERAPY ON REMISSION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE NEW ACR/EULAR REMISSION CRITERIA IN DAILY PRACTICE BASED ON THE IORRA COHORT
    Shimizu, Y.
    Tanaka, E.
    Inoue, E.
    Shidara, K.
    Hoshi, D.
    Sugimoto, N.
    Sato, E.
    Seto, Y.
    Momohara, S.
    Nakajima, A.
    Taniguchi, A.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 342 - 342
  • [28] Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes
    Wechalekar, Mihir D.
    Lester, Susan
    Rischmueller, Maureen
    Hill, Catherine
    Proudman, Susanna
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [29] DIFFERENCES IN PHYSICIAN-REPORTED AND DAS28-BASED ASSESSMENT OF DISEASE REMISSION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN CLINICAL PRACTICES
    Wei, W.
    Chen, C.
    Sullivan, E.
    Blackburn, S.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 118 - 119
  • [30] LONG TERM OUTCOMES OF STOPPING TUMOUR NECROSIS FACTOR INHIBITORS (TNFI) IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS (RA) WHO ARE IN SUSTAINED REMISSION: IS IT WORTH THE RISK?
    Rakieh, C.
    Saleem, B.
    Takase, K.
    Nam, J. L.
    Keen, H.
    Wakefield, R. J.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 208 - 209